Table 2.
Correlation between LATS2 expression and clinicopathological features
Patient characteristics | n | LATS2 | P | |
---|---|---|---|---|
– | + | |||
Gender | 0.973 | |||
Male | 135 | 88 | 47 | |
Female | 29 | 19 | 10 | |
Age | 0.881 | |||
≤ 58 | 85 | 55 | 30 | |
> 58 | 79 | 52 | 27 | |
Tumor diameter | 0.077 | |||
<5 cm | 106 | 64 | 42 | |
≥ 5 cm | 58 | 43 | 15 | |
Tumor location | 0.603 | |||
Upper | 15 | 9 | 6 | |
Middle | 104 | 66 | 38 | |
Lower | 45 | 32 | 13 | |
T stage | 0.182 | |||
T1–2 | 69 | 41 | 28 | |
T3–4 | 95 | 66 | 29 | |
Lymph node metastasis | 0.003 | |||
Negative | 104 | 59 | 45 | |
Positive | 60 | 48 | 12 | |
Histological grade | 0.028 | |||
Well | 31 | 17 | 14 | |
Middle | 97 | 60 | 37 | |
Poor | 36 | 30 | 6 | |
pTNM stage | 0.005 | |||
I | 28 | 14 | 14 | |
II | 85 | 51 | 34 | |
III | 51 | 42 | 9 |